| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |